[Validation of a ultramicroELISA for detecting antibodies against hepatitis B surface antigen]. 1996

L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
Instituto de Medicina Tropical Pedro Kouri.

The results of a validation study of the ultramicroanalitical assay for the detection of antibodies against the hepatitis B surface antigen (UMELISA anti-HBsAg), which was carried out by comparing the results obtained with the Hepanostika anti-HBsAg, commercial diagnosis kit are presented. For this purpose, sera from the clinical assays of the Cuban recombinant vaccine against hepatitis B were used. With the first sera group (n = 30) it was obtained, 93.1% of sensitivity, 98.5% of specificity and a concordance of 94.3%. The correlation coefficient showed a similar trend of the results (p < 0.01) and no significant differences were found in the average geometrical titre (TPG) between both assays (p > 0.05). With the second group (n = 100), whose assays were carried out at the "Pedro Kouri" Institute of Tropical Medicine (PKI) and at the Immunoassay Center (IAC) simultaneously, it was observed a sensitivity of 96.25% in both centers, a specificity of 75% at the PKI and of 90% at the IAC, and a coincidence of 92% and 95%, respectively. The correlation coefficient presented similar values and there were no significant differences between the TPG obtained by the two methods (p > 0.05). The results attained show in general the validity of the new assay and the feasibility to put it into practice either for following up the infection, or for carrying out clinical assays of vaccine evaluations.

UI MeSH Term Description Entries
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
March 1977, Diabete & metabolisme,
L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
February 2006, Emerging infectious diseases,
L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
October 1985, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
October 1989, Molekuliarnaia genetika, mikrobiologiia i virusologiia,
L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
January 1984, Journal of medical virology,
L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
November 1985, Annals of internal medicine,
L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
January 1992, Human antibodies and hybridomas,
L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
February 1983, Infection and immunity,
L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
April 2013, Monoclonal antibodies in immunodiagnosis and immunotherapy,
L Rodríguez, and A Balmaseda, and J Bravo, and J Trujillo, and L Martínez, and R Ochoa, and M Díaz, and J Laferté, and F Ramos
January 1983, Journal of virological methods,
Copied contents to your clipboard!